Login to Your Account

Santaris Raises €20M For LNA-Based Drug Portfolio

By Cormac Sheridan

Wednesday, December 19, 2007

No Abstract


BioWorld International Correspondent

Santaris Pharma A/S raised €20.4 million (US$29.4 million) in a new investment round led by Gilde Healthcare Partners BV, of Utrecht, the Netherlands, which contributed €7.5 million of the total.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription